EMMA KERR: Open Payments
NPI 1891562864 · SWEDESBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 58 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $584 · 2025 $1,083
Food & beverage: $1,004Education: $79
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $399 |
| GlaxoSmithKline, LLC. | 31 | $397 |
| Regeneron Healthcare Solutions, Inc. | 6 | $93 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Philips North America LLC | 2 | $34 |
| Verona Pharma, Inc. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| United Therapeutics Corporation | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, Vest Therapy Und, Ohtuvayre, PURIFIED CORTROPHIN GEL, TEZSPIRE, Tyvaso.
Industry payments across NJ — which companies pay providers there.
